FDA Grand Rounds, Why FDA authorized the marketing of the IQOS heated tobacco product as “appropriate for the protection of the public health," 10/10/2019, 12-1pm EST, presented by Priscilla Callahan-Lyon, M.D.

TimeZone (UTC)

Priscilla Callahan-Lyon, M.D.

Priscilla Callahan-Lyon, M.D.
Deputy Director, Division of Individual Health Science
Office of Science, Center for Tobacco Products

About the Speaker:

After 20 years of private medical practice as an internist and pulmonologist, Dr. Priscilla Callahan-Lyon joined FDA in 2008 as a medical reviewer in the Center for Drug Evaluation and Research where she worked extensively on nicotine replacement therapies. She moved to the Center for Tobacco Products (CTP) in 2012 and currently serves as Deputy Director for the Division of Individual Health Science in CTP’s Office of Science. Dr. Callahan is a member of several FDA cross-center groups that are involved with nicotine policy and regulation. She also serves as the FDA contact on the Tri-Agency workgroup (CDC, NIH, and FDA) focusing on smoking cessation.

If you've never used Adobe Connect, get a quick overview: http://www.adobe.com/products/adobeconnect.html
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks
of Adobe Systems Incorporated in the United States and/or other countries.